You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Anti-androgen therapy with cyproterone acetate (CPA) can reduce the epithelial component of benign prostatic hyperplasia (BPH). Clinical results from 20 BPH patients treated with CPA demonstrate its efficacy.
Area of Science:
Context:
Purpose:
Summary:
Impact: